Oral Fluid Testing for Drugs of Abuse

被引:292
作者
Bosker, Wendy M. [1 ,2 ]
Huestis, Marilyn A. [2 ]
机构
[1] Maastricht Univ, Fac Psychol & Neurosci Neuropsychol Psychopharmac, Expt Psychopharmacol Unit, Maastricht, Netherlands
[2] Natl Inst Drug Abuse, NIH, Baltimore, MD USA
关键词
CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE EXTRACTION; LC-MS-MS; PERFORMANCE LIQUID-CHROMATOGRAPHY; METABOLITE 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID; COZART(R) MICROPLATE EIA; CANNABIS SMOKE EXPOSURE; MULTIPLE ILLICIT DRUGS; GAS-CHROMATOGRAPHY; GC-MS;
D O I
10.1373/clinchem.2008.108670
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Oral fluid (OF) is an exciting alternative matrix for monitoring drugs of abuse in workplace, clinical toxicology, criminal justice, and driving under the influence of drugs (DUID) programs. During the last 5 years, scientific and technological advances in OF collection, point-of-collection testing devices, and screening and confirmation methods were achieved. Guidelines were proposed for workplace OF testing by the Substance Abuse and Mental Health Services Administration, DUID testing by the European Union's Driving under the Influence of Drugs, Alcohol and Medicines (DRUID) program, and standardization of DUID research. Although OF testing is now commonplace in many monitoring programs, the greatest current limitation is the scarcity of controlled drug administration studies available to guide interpretation. CONTENT: This review outlines OF testing advantages and limitations, and the progress in OF that has occurred during the last 5 years in collection, screening, confirmation, and interpretation of cannabinoids, opioids, amphetamines, cocaine, and benzodiazepines. We examine controlled drug administration studies, immunoassay and chromatographic methods, collection devices, point-of-collection testing device performance, and recent applications of OF testing. SUMMARY: Substance Abuse and Mental Health Services Administration approval of OF testing was delayed because questions about drug OF disposition were not yet resolved, and collection device performance and testing assays required improvement. Here, we document the many advances achieved in the use Of OF. Additional research is needed to identify new biomarkers, determine drug detection windows, characterize OF adulteration techniques, and evaluate analyte stability. Nevertheless, there is no doubt that OF offers multiple advantages as an alternative matrix for drug monitoring and has an important role in DUID, treatment, workplace, and criminal justice programs. (C) 2009 American Association for Clinical Chemistry
引用
收藏
页码:1910 / 1931
页数:22
相关论文
共 130 条
[1]  
Ananias D, 2007, THER DRUG MONIT, V29, P493
[2]   Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant Direct ELISA presumptive assays for amphetamine and methamphetamine [J].
Apollonio, Luigino G. ;
Whittall, Ian R. ;
Pianca, Dennis J. ;
Kyd, Jennelle M. ;
Maher, William A. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2007, 31 (04) :208-213
[3]   Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart® opiate microplate EIA and GC-MS following controlled codeine administration [J].
Barnes, AJ ;
Kim, I ;
Schepers, R ;
Moolchan, ET ;
Wilson, L ;
Cooper, G ;
Reid, C ;
Hand, C ;
Huestis, MA .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2003, 27 (07) :402-406
[4]   Drugs in injured drivers in Denmark [J].
Bernhoft, IM ;
Steentoft, A ;
Johansen, SS ;
Klitgaard, NA ;
Larsen, LB ;
Hansen, LB .
FORENSIC SCIENCE INTERNATIONAL, 2005, 150 (2-3) :181-189
[5]   On-site testing of illicit drugs:: the use of the drug-testing device "Toxiquick®" [J].
Biermann, T ;
Schwarze, B ;
Zedler, B ;
Betz, R .
FORENSIC SCIENCE INTERNATIONAL, 2004, 143 (01) :21-25
[6]   The US Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current status and future considerations [J].
Bush, Donna M. .
FORENSIC SCIENCE INTERNATIONAL, 2008, 174 (2-3) :111-119
[7]   A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam [J].
Busto, UE ;
Kaplan, HL ;
Wright, CE ;
Gomez-Mancilla, B ;
Zawertailo, L ;
Greenblatt, DJ ;
Sellers, EM .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (06) :628-635
[8]   Use of gas chromatography/mass spectrometry with positive chemical ionization for the determination of opiates in human oral fluid [J].
Cámpora, P ;
Bermejo, AM ;
Tabernero, MJ ;
Fernández, P .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (08) :1288-1292
[9]   DISPOSITION AND METABOLISM OF CODEINE AFTER SINGLE AND CHRONIC DOSES IN ONE POOR AND 7 EXTENSIVE METABOLIZERS [J].
CHEN, ZR ;
SOMOGYI, AA ;
REYNOLDS, G ;
BOCHNER, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) :381-390
[10]   Oral fluid as a diagnostic tool [J].
Choo, RE ;
Huestis, MA .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (11) :1273-1287